Literature DB >> 23164386

The prevalence and overlap of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome in men: results of the RAND Interstitial Cystitis Epidemiology male study.

Anne M Suskind1, Sandra H Berry, Brett A Ewing, Marc N Elliott, Marika J Suttorp, J Quentin Clemens.   

Abstract

PURPOSE: As part of the RICE (RAND Interstitial Cystitis Epidemiology) study, we developed validated case definitions to identify interstitial cystitis/bladder pain syndrome in women and chronic prostatitis/chronic pelvic pain syndrome in men. Using population based screening methods, we applied these case definitions to determine the prevalence of these conditions in men.
MATERIALS AND METHODS: A total of 6,072 households were contacted by telephone to screen for men who had symptoms of interstitial cystitis/bladder pain syndrome or chronic prostatitis/chronic pelvic pain syndrome. An initial 296 men screened positive, of whom 149 met the inclusionary criteria and completed the telephone interview. For interstitial cystitis/bladder pain syndrome 2 case definitions were applied (1 with high sensitivity and 1 with high specificity), while for chronic prostatitis/chronic pelvic pain syndrome a single case definition (with high sensitivity and specificity) was used. These case definitions were used to classify subjects into groups based on diagnosis.
RESULTS: The interstitial cystitis/bladder pain syndrome weighted prevalence estimates for the high sensitivity and high specificity definitions were 4.2% (3.1-5.3) and 1.9% (1.1-2.7), respectively. The chronic prostatitis/chronic pelvic pain syndrome weighted prevalence estimate was 1.8% (0.9-2.7). These values equate to 1,986,972 (95% CI 966,042-2,996,924) men with chronic prostatitis/chronic pelvic pain syndrome and 2,107,727 (95% CI 1,240,485-2,974,969) men with the high specificity definition of interstitial cystitis/bladder pain syndrome in the United States. The overlap between men who met the high specificity interstitial cystitis/bladder pain syndrome case definition or the chronic prostatitis/chronic pelvic pain syndrome case definition was 17%.
CONCLUSIONS: Symptoms of interstitial cystitis/bladder pain syndrome and chronic prostatitis/chronic pelvic pain syndrome are widespread among men in the United States. The prevalence of interstitial cystitis/bladder pain syndrome symptoms in men approaches that in women, suggesting that this condition may be underdiagnosed in the male population.
Copyright © 2013 American Urological Association Education and Research, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23164386      PMCID: PMC3894747          DOI: 10.1016/j.juro.2012.08.088

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  22 in total

1.  Prevalence of prostatitis-like symptoms in a managed care population.

Authors:  J Quentin Clemens; Richard T Meenan; Maureen C O'Keeffe-Rosetti; Sara Y Gao; Sheila O Brown; Elizabeth A Calhoun
Journal:  J Urol       Date:  2006-08       Impact factor: 7.450

2.  Prevalence of prostatitis-like symptoms in Japanese men: Population-based study in a town in Hokkaido.

Authors:  Yasuharu Kunishima; Mitsuru Mori; Hiroshi Kitamura; Hiroshi Satoh; Taiji Tsukamoto
Journal:  Int J Urol       Date:  2006-10       Impact factor: 3.369

3.  Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men.

Authors:  Jochen Walz; Paul Perrotte; Georg Hutterer; Nazareno Suardi; Claudio Jeldres; Francois Bénard; Luc Valiquette; Pierre I Karakiewicz
Journal:  BJU Int       Date:  2007-10-17       Impact factor: 5.588

4.  Overlap of voiding symptoms, storage symptoms and pain in men and women.

Authors:  J Quentin Clemens; Talar W Markossian; Richard T Meenan; Maureen C O'Keeffe Rosetti; Elizabeth A Calhoun
Journal:  J Urol       Date:  2007-08-16       Impact factor: 7.450

5.  Association between past urinary tract infections and current symptoms suggestive of chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Nicholas A Daniels; Carol L Link; Michael J Barry; John B McKinlay
Journal:  J Natl Med Assoc       Date:  2007-05       Impact factor: 1.798

6.  Predictors of symptom severity in patients with chronic prostatitis and interstitial cystitis.

Authors:  J Quentin Clemens; Sheila O Brown; Lara Kozloff; Elizabeth A Calhoun
Journal:  J Urol       Date:  2006-03       Impact factor: 7.450

7.  Prevalence and psychosocial correlates of symptoms suggestive of painful bladder syndrome: results from the Boston area community health survey.

Authors:  Carol L Link; Samantha J Pulliam; Philip M Hanno; Susan A Hall; Paul W Eggers; John W Kusek; John B McKinlay
Journal:  J Urol       Date:  2008-06-12       Impact factor: 7.450

8.  The relationship of common medical conditions and medication use with symptoms of painful bladder syndrome: results from the Boston area community health survey.

Authors:  Susan A Hall; Carol L Link; Samantha J Pulliam; Philip M Hanno; Paul W Eggers; John W Kusek; John B McKinlay
Journal:  J Urol       Date:  2008-06-12       Impact factor: 7.450

9.  Interstitial cystitis and painful bladder syndrome.

Authors:  Christopher K Payne; Geoffrey F Joyce; Matthew Wise; J Quentin Clemens
Journal:  J Urol       Date:  2007-06       Impact factor: 7.450

10.  Prevalence, symptom impact and predictors of chronic prostatitis-like symptoms in Canadian males aged 16-19 years.

Authors:  Dean A Tripp; J Curtis Nickel; Stephanie Ross; Chris Mullins; Natalie Stechyson
Journal:  BJU Int       Date:  2008-10-24       Impact factor: 5.588

View more
  64 in total

1.  Adverse Childhood Experiences and Symptoms of Urologic Chronic Pelvic Pain Syndrome: A Multidisciplinary Approach to the Study of Chronic Pelvic Pain Research Network Study.

Authors:  Andrew Schrepf; Bruce Naliboff; David A Williams; Alisa J Stephens-Shields; J Richard Landis; Arpana Gupta; Emeran Mayer; Larissa V Rodriguez; Henry Lai; Yi Luo; Catherine Bradley; Karl Kreder; Susan K Lutgendorf
Journal:  Ann Behav Med       Date:  2018-09-13

2.  Efficacy, Side Effects, and Monitoring of Oral Cyclosporine in Interstitial Cystitis-Bladder Pain Syndrome.

Authors:  Iryna M Crescenze; Barbara Tucky; Jianbo Li; Courtenay Moore; Daniel A Shoskes
Journal:  Urology       Date:  2017-05-18       Impact factor: 2.649

Review 3.  Urologic chronic pelvic pain syndrome: insights from the MAPP Research Network.

Authors:  J Quentin Clemens; Chris Mullins; A Lenore Ackerman; Tamara Bavendam; Adrie van Bokhoven; Benjamin M Ellingson; Steven E Harte; Jason J Kutch; H Henry Lai; Katherine T Martucci; Robert Moldwin; Bruce D Naliboff; Michel A Pontari; Siobhan Sutcliffe; J Richard Landis
Journal:  Nat Rev Urol       Date:  2019-03       Impact factor: 14.432

4.  Physical activity and chronic prostatitis/chronic pelvic pain syndrome.

Authors:  Ran Zhang; Andrea K Chomistek; Jordan D Dimitrakoff; Edward L Giovannucci; Walter C Willett; Bernard A Rosner; Kana Wu
Journal:  Med Sci Sports Exerc       Date:  2015-04       Impact factor: 5.411

5.  Risk of associated conditions in relatives of subjects with interstitial cystitis.

Authors:  Kristina Allen-Brady; Peggy A Norton; Lisa Cannon-Albright
Journal:  Female Pelvic Med Reconstr Surg       Date:  2015 Mar-Apr       Impact factor: 2.091

6.  CUA guideline: Diagnosis and treatment of interstitial cystitis/bladder pain syndrome.

Authors:  Ashley Cox; Nicole Golda; Genevieve Nadeau; J Curtis Nickel; Lesley Carr; Jacques Corcos; Joel Teichman
Journal:  Can Urol Assoc J       Date:  2016-05-12       Impact factor: 1.862

7.  Morbidity rate and medical utilization in interstitial cystitis/painful bladder syndrome.

Authors:  Ming-Huei Lee; Kun-Min Chang; Wen-Chen Tsai
Journal:  Int Urogynecol J       Date:  2018-03-12       Impact factor: 2.894

8.  Clinical and Psychosocial Predictors of Urological Chronic Pelvic Pain Symptom Change in 1 Year: A Prospective Study from the MAPP Research Network.

Authors:  Bruce D Naliboff; Alisa J Stephens; H Henry Lai; James W Griffith; J Quentin Clemens; Susan Lutgendorf; Larissa V Rodriguez; Craig Newcomb; Siobhan Sutcliffe; Wensheng Guo; John W Kusek; J Richard Landis
Journal:  J Urol       Date:  2017-05-18       Impact factor: 7.450

9.  Elevated Urine Levels of Macrophage Migration Inhibitory Factor in Inflammatory Bladder Conditions: A Potential Biomarker for a Subgroup of Interstitial Cystitis/Bladder Pain Syndrome Patients.

Authors:  Pedro L Vera; David M Preston; Robert M Moldwin; Deborah R Erickson; Behzad Mowlazadeh; Fei Ma; Dimitrios E Kouzoukas; Katherine L Meyer-Siegler; Magnus Fall
Journal:  Urology       Date:  2018-03-23       Impact factor: 2.649

10.  The X-Y factor: Females and males with urological chronic pelvic pain syndrome present distinct clinical phenotypes.

Authors:  Gregory W Hosier; R Christopher Doiron; Victoria Tolls; J Curtis Nickel
Journal:  Can Urol Assoc J       Date:  2018-02-23       Impact factor: 1.862

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.